Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

EW Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 08, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Edwards Lifesciences Corp (EW)

Based on 43 analysts giving stock ratings to Edwards Lifesciences Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
26
Buy
46
Hold
28
Sell
0
Strong Sell
0
Edwards Lifesciences Corp

Edwards Lifesciences Corp. Stock Analysis EW

United States Health Care Large Cap Report:
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 16,000 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
Read More

Edwards Lifesciences Corp (EW) Chart

Key Statistics of Edwards Lifesciences Corp (EW)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$85.46$87.22

Today's Open

$86.19

Volume

4.23M

P/E Ratio (TTM)

46.41

52 Week Range

$72.30$89.60

Market Cap

47.91B

Avg. Volume

5.04M

Dividend Yield

-

Financial Metrics & Statements of Edwards Lifesciences Corp (EW)

FAQ's for Edwards Lifesciences Corp (EW)

  • According to Musaffa’s Shariah screening methodology, Edwards Lifesciences Corp (EW) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Edwards Lifesciences Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Edwards Lifesciences Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Edwards Lifesciences Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Edwards Lifesciences Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Edwards Lifesciences Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.